| Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study M AlJumah, R Bunyan, H Al Otaibi, G Al Towaijri, A Karim, Y Al Malik, ... BMC neurology 20, 1-7, 2020 | 118 | 2020 |
| Potentially inappropriate medications in older patients based on Beers criteria: a cross-sectional study of a family medicine practice in Saudi Arabia A Alturki, T Alaama, Y Alomran, A Al-Jedai, H Almudaiheem, G Watfa BJGP open 4 (1), 2020 | 32 | 2020 |
| Cost-efficiency of of national drug information center through ministry of healh hotline calling services (937) in Saudi Arabia: application of a Mercian Model YA Alomi, HY Almudaiheem, T Alarnous, S Alshurei, A Alsharafa, ... Value in Health 18 (7), A735, 2015 | 25 | 2015 |
| Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy GB Korayem, HA Badreldin, K Eljaaly, A Aldemerdash, LK Al-Suhaibani, ... Saudi Pharmaceutical Journal 29 (11), 1343-1347, 2021 | 24 | 2021 |
| Clinical and economic outcomes of pharmacist intervention during therapeutic drug monitoring program in Saudi Arabia YA Alomi, HY Almudaiheem Value in Health 19 (7), A465-A466, 2016 | 14 | 2016 |
| Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease MH Mosli, HY Almudaiheem, T AlAmeel, SA Bakkari, OR Alharbi, ... Saudi Journal of Gastroenterology 29 (Suppl 1), S1-S35, 2023 | 12 | 2023 |
| Informing a cost-effectiveness threshold for Saudi Arabia AH Al-Jedai, J Lomas, HY Almudaiheem, YSH Al-Ruthia, S Alghamdi, ... Journal of Medical Economics 26 (1), 128-138, 2023 | 11 | 2023 |
| Restriction on antimicrobial dispensing without prescription on a national level: impact on the overall antimicrobial utilization in the community pharmacies in Saudi Arabia AH Al-Jedai, Y Almogbel, K Eljaaly, NM Alqahtani, HY Almudaiheem, ... PLoS One 17 (7), e0271188, 2022 | 10 | 2022 |
| National Saudi consensus statement on the management of atopic dermatitis (2021) MI Fatani, AA Al Sheikh, MA Alajlan, RS Alharithy, Y Binamer, ... Dermatology and Therapy 12 (7), 1551-1575, 2022 | 10 | 2022 |
| Diagnosis and management of alopecia areata: a Saudi expert consensus statement (2023) MIA Fatani, A Alkhalifah, AFS Alruwaili, AHS Alharbi, R Alharithy, ... Dermatology and Therapy 13 (10), 2129-2151, 2023 | 9 | 2023 |
| Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelines MA Omair, H Al Rayes, J Khabsa, S Yaacoub, S Abdulaziz, GA Al Janobi, ... BMC rheumatology 6 (1), 70, 2022 | 8 | 2022 |
| Prevalence of pediatric onset multiple sclerosis in Saudi Arabia R Bunyan, G Al Towaijri, H Al Otaibi, A Kareem, H Algahtani, M Al Mejally, ... Multiple Sclerosis International 2021 (1), 4226141, 2021 | 7 | 2021 |
| Cost efficiency of national drug information center services through ministry of health hotline calling center (937) in Saudi Arabia YA Alomi, HY Almudaiheem International Journal of Pharmacology and Clinical Sciences 8 (1), 2019 | 7 | 2019 |
| Burden of illness of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: a five-year longitudinal study M AlHarbi, A Othman, AA Nahari, AH Al-Jedai, D Cuadras, F Almalky, ... Advances in Therapy 41 (3), 1120-1150, 2024 | 6 | 2024 |
| Prevalence and epidemiological trends in mortality due to COVID-19 in Saudi Arabia DA Alissa, W Aburas, R Almasuood, HY Almudaiheem, Z Al Aseri, ... Public Health 215, 31-38, 2023 | 6 | 2023 |
| Cost of cardiovascular diseases and renal complications in people with type 2 diabetes mellitus in the Kingdom of Saudi Arabia: a retrospective analysis of claims database AH Al-Jedai, HY Almudaiheem, DA Alissa, HS Al-Enazy, GB Korayem, ... Plos one 17 (10), e0273836, 2022 | 6 | 2022 |
| Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: a national representative study A Al-Jedai, H Almudaiheem, T Al-Salamah, M Aldosari, AR Almutairi, ... Value in Health 27 (5), 552-561, 2024 | 5 | 2024 |
| Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020) MIA Fatani, IRA Hamadah, MA Alajlan, Y Binamer, AHS Alharbi, ... Journal of Dermatological Treatment 33 (4), 1916-1930, 2022 | 5 | 2022 |
| Clinical pharmacist core competencies in Saudi Arabia: A position paper by the Saudi Society of Clinical Pharmacy HA Badreldin, A Aldemerdash, O Aljuhani, H Joharji, BA Al-Omari, ... Saudi Journal of Clinical Pharmacy 1 (2), 47-51, 2022 | 5 | 2022 |
| Clinical outcomes of Vancomycin therapeutic monitoring services at Ministry of Health hospital in Saudi Arabia YA Alomi, HY Almudaiheem VALUE IN HEALTH 20 (5), A42-A42, 2017 | 5 | 2017 |
Ahmed Al-jedaiTherapeutic Affairs, MOH and Professor of Clinical Pharmacy, Alfaisal UniversityΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα alfaisal.edu